(no title)
spartango | 11 years ago
* Genomic Health ($GHDX) with OncotypeDX
* Foundation Medicine ($FMI) with FoundationOne
Both of these companies have tests on the market that analyze tumor genomes (sequencing or microarray-based) and provide information to oncologists to better treat their patients. Information like drug efficacy and tumor aggressiveness (requiring chemo-/radiotherapy).
No comments yet.